FACGX Performance — Fidelity Advisor Growth Opportunities Fund, Class C
Data updated: 2026-07-24
FACGX returned +15.60% year to date and +40.92% over one year to May 2026. Over one year the fund beat its US Large Growth category average: $100 grew to $141, against $125 for the category. Volatility over the past 12 months was 22.14% a year. In the 12 months to May 2026 the fund took in a net $706.6M, and assets reached $35.28B.
FACGX Growth of $100
What $100 invested in Fidelity Advisor Growth Opportunities Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | FACGX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $141 | $125 |
| 3 years (Jun 2023 – May 2026) | $185 | $187 |
| 5 years (Jun 2021 – May 2026) | $115 | $176 |
| Since data start (Sep 2019 – May 2026) | $184 | $274 |
FACGX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.60% |
| 1 year | +40.92% |
3- and 5-year figures withheld: disagrees with sibling classes.
FACGX Annual Returns
Calendar-year total returns of Fidelity Advisor Growth Opportunities Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +15.60% |
| 2025 | +18.85% |
| 2024 | +22.54% |
| 2023 | +28.33% |
| 2022 | −45.71% |
| 2021 | −1.79% |
| 2020 | +49.37% |
| 2019 (Sep–Dec) | +6.70% |
FACGX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.0% | −3.2% | −5.7% | +17.3% | +9.1% | — | — | — | — | — | — | — |
| 2025 | +2.7% | −5.8% | −9.9% | +0.6% | +11.2% | +8.7% | +4.9% | +0.8% | +4.7% | +2.8% | −2.1% | +0.7% |
| 2024 | +1.2% | +8.2% | +1.8% | −5.4% | +5.8% | +4.8% | −4.0% | +2.1% | +2.9% | −0.1% | +5.1% | −1.1% |
| 2023 | +9.9% | −2.8% | +3.9% | −2.0% | +7.0% | +4.9% | +5.7% | −5.0% | −6.3% | −4.6% | +11.2% | +5.2% |
| 2022 | −14.5% | −2.9% | +1.2% | −16.8% | −2.9% | −12.2% | +9.8% | −2.8% | −11.6% | +3.6% | +3.1% | −9.7% |
| 2021 | +0.9% | +1.4% | −3.2% | +4.7% | −3.4% | +5.9% | −1.2% | +2.9% | −6.1% | +4.8% | −5.5% | −2.1% |
| 2020 | +1.7% | −5.9% | −13.6% | +17.9% | +8.5% | +7.9% | +7.2% | +11.0% | −4.6% | −3.3% | +13.4% | +5.0% |
| 2019 | — | — | — | — | — | — | — | — | −4.2% | +4.2% | +5.2% | +1.6% |
FACGX Risk
Risk measures from monthly returns over Jun 2025 – May 2026.
- 1-year volatility (annualised): 22.14%
- Best month: +17.33% (Apr 2026)
- Worst month: −5.71% (Mar 2026)
FACGX Fund Flows
Monthly money in and out of Fidelity Advisor Growth Opportunities Fund, from SEC Form N-PORT.
- 12-month net flow: $706.6M
- 12-month gross sales (incl. reinvestments): $8.0B
- Sales ÷ redemptions: 1.10×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $578.7M | $597.7M | −$19.1M |
| Apr 2026 | $649.5M | $570.4M | $79.1M |
| Mar 2026 | $604.7M | $529.7M | $75.1M |
| Feb 2026 | $960.2M | $1.0B | −$68.7M |
| Jan 2026 | $664.7M | $568.0M | $96.7M |
| Dec 2025 | $1.6B | $794.9M | $787.0M |
| Nov 2025 | $507.3M | $451.3M | $56.0M |
| Oct 2025 | $547.8M | $538.0M | $9.8M |
| Sep 2025 | $507.3M | $831.3M | −$324.1M |
| Aug 2025 | $498.5M | $432.4M | $66.1M |
| Jul 2025 | $514.2M | $564.1M | −$49.9M |
| Jun 2025 | $422.4M | $423.9M | −$1.5M |
FACGX Assets Under Management
Net assets of Fidelity Advisor Growth Opportunities Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $35.28B |
| 2026-02-28 | $29.03B |
| 2025-11-30 | $30.35B |
| 2025-08-31 | $29.00B |
| 2025-05-31 | $25.18B |
| 2025-02-28 | $24.71B |
| 2024-11-30 | $24.94B |
| 2024-08-31 | $22.46B |
| 2024-05-31 | $21.19B |
| 2024-02-29 | $20.28B |
| 2023-11-30 | $17.28B |
| 2023-08-31 | $16.96B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.